首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1747535

卵巢（PCOS）治疗市场（按药物类别、分销管道和地区）

Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, By Distribution Channel, By Region

出版日期: 2025年05月02日 | 出版商:

Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3个工作天内

价格

简介目录

卵巢症候群 (PCOS) 治疗市场预计在 2025 年达到 11.952 亿美元，到 2032 年将达到 16.661 亿美元，2025 年至 2032 年的复合年增长率为 4.86%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	11.952亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	4.86%	2032年价值预测	16.661亿美元

卵巢症候群 (PCOS) 是一种由于内分泌系统失调导致卵巢内形成充满液体的小囊的疾病。它会影响患有 PCOS 的育龄女性。 PCOS 阳性女性更容易出现流产、妊娠期糖尿病、妊娠高血压、妊娠毒血症和早产。此外，PCOS 女性还可能出现月经、雄性激素（性荷尔蒙）水平升高、毛髮过度生长、痤疮和肥胖。

多囊性卵巢症候群 (PCOS) 女性更容易出现严重的健康问题，包括第 2 型糖尿病、高血压、心血管疾病以及子宫癌。 PCOS 女性通常难以怀孕（不孕）。

市场动态

口服避孕药的有效使用和产品价值的提高可能会在预测期内推动卵巢症候群 (PCOS) 治疗市场的发展。例如，2022 年 8 月发表在 NCBI 上的一篇论文指出，在 PCOS 的治疗中，口服避孕药 (OC) 的主要作用机制是控制月经。这些药物还可以透过降低睪固酮水平来减少多毛症和痤疮。因此，口服避孕药是卵巢症候群 (PCOS) 的主要治疗方法。

此外，随着人们对卵巢症候群 (PCOS) 治疗新机制的认识不断提高，预计将在预测期内推动市场成长。例如，中华医学会妇产科分会于 2020 年 11 月发表的一项研究表明，电针 (EA) 干预透过调节脂质代谢调节剂 SREBP1 改善胰岛素抗性 (IR)、粒线体功能障碍和氧化压力，从而缓解大鼠的 PCOS 样症状。该研究结果揭示了电针在 PCOS 治疗中的一种新型保护机制。

本研究的主要特点

本报告对全球卵巢症候群 (PCOS) 治疗市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和年复合成长率（CAGR%）。
它揭示了各个领域的潜在商机，并说明了该市场的一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球卵巢症候群 (PCOS) 治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数列出的。
全球卵巢症候群 (PCOS) 治疗市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球卵巢症候群 (PCOS) 治疗市场的各种策略矩阵来促进决策。

Sanofi SA
Amneal Pharmaceuticals, Inc.
Laurus Labs Limited
Zydus Pharmaceuticals, Inc.
Prasco Laboratories
Reddy's Laboratories
Cadila Pharmaceuticals
Novartis International AG
Concordia Pharmaceuticals Inc.
Covis Pharmaceuticals, Inc.
Cardinal Health
Aphena Pharma Solutions Tennessee, Inc.
Mylan NV
McKesson Corporation
Teva Pharmaceutical Industries Ltd
Lupin Pharmaceutical
Sun Pharmaceutical Industries Ltd.

第九章章节

调查方法
关于出版商

简介目录

Product Code: CMI1589

Polycystic Ovary Syndrome (PCOS) Treatment Market is expected to be USD 1,195.2 Mn in 2025 and is anticipated to reach USD 1,666.1 Mn in 2032 at a compound annual growth rate (CAGR) of 4.86% for the forecast period of 2025 to 2032

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1,195.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.86%	2032 Value Projection:	USD 1,666.1 Mn

Polycystic Ovarian Syndrome (PCOS) can be described as small sacs filled with fluid develop on the ovaries as a result of the endocrine system condition. Women with PCOS who are of childbearing age are affected. PCOS-positive women are more likely to experience miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and early birth. Moreover, women with PCOS may experience irregular menstrual cycles, elevated androgen (sex hormone) levels, excessive hair growth, acne, and obesity.

Women who have PCOS are more likely to develop serious health issues. These include type 2 diabetes, high blood pressure, heart and blood vessel problems, and uterine cancer. Women suffering from PCOS frequently struggle to conceive (fertility).

Market Dynamics

Effective use of oral contraceptives and increasing product value can drive the polycystic ovary syndrome (PCOS) treatment market over the forecast period. For instance, in August 2022, an article was published in the NCBI, according to which, for the treatment of PCOS, the major mechanism of action of oral contraceptives (OCs) is to control menstruation. These drugs also reduce hirsutism and acne by lowering testosterone levels. Thus, oral contraceptives are primary treatment for the polycystic ovary syndrome.

Moreover, rising awareness about novel mechanisms in the treatment of Polycystic Ovary Syndrome (PCOS) is anticipated to boost the growth of the market over the forecast period. For instance, according to research study published by Department of Obstetrics and Gynecology, China in November 2020, stated that the electroacupuncture (EA) intervention alleviated PCOS-like symptoms in rats by improving IR, mitochondrial dysfunction and oxidative stress through regulation of SREBP1, a regulator of lipid metabolism. The study findings illuminate the novel protective mechanisms of EA in the treatment of PCOS.

Key features of the study:

This report provides in-depth analysis of the global Polycystic Ovary Syndrome (PCOS) Treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Polycystic Ovary Syndrome (PCOS) Treatment Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Key companies covered as a part of this study Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Evotec SE, Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical and Sun Pharmaceutical Industries Ltd., Bayer AG, and other prominent players Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Polycystic Ovary Syndrome (PCOS) Treatment Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Polycystic Ovary Syndrome (PCOS) Treatment Market

Market Segmentation

By Drug Class
- Oral contraceptives
- Insulin Sensitizing Agents
- Anti-Depressants
- Ornithine Decarboxylase Inhibitors
- Aromatase Inhibitors & SERMs
- Diuretics
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Sanofi S.A.
- Amneal Pharmaceuticals, Inc.
- Laurus Labs Limited
- Zydus Pharmaceuticals, Inc.
- Prasco Laboratories
- Reddy's Laboratories
- Cadila Pharmaceuticals
- Novartis International AG
- Concordia Pharmaceuticals Inc.
- Covis Pharmaceuticals, Inc.
- Cardinal Health
- Aphena Pharma Solutions Tennessee, Inc.
- Mylan N.V.
- McKesson Corporation
- Teva Pharmaceutical Industries Ltd
- Lupin Pharmaceutical
- Sun Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Epidemiology
Regulatory Scenario
Product Launches
Merger, Acquisition, Collaborations
Key Developments
Market Trends
PEST Analysis
PORTER'S Analysis
Risk and Adverse Effects
New Investments by Major Market Players
Pipeline Analysis
Supply Chain Analysis
Pricing Analysis
Brand Analysis

4. Global Polycystic Ovary Syndrome (PCOS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Clinical Trials

5. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, 2020 - 2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Insulin Sensitizing Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Anti- Depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Ornithine Decarboxylase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Aromatase Inhibitors & SERMs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Distribution Channel, 2020 - 2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region, 2020 - 2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032(%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Laurus Labs Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zydus Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Prasco Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cadila Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Concordia Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Covis Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aphena Pharma Solutions Tennessee, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lupin Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

卵巢（PCOS）治疗市场（按药物类别、分销管道和地区）

Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, By Distribution Channel, By Region

市场动态

本研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 全球卵巢症候群 (PCOS) 治疗市场-冠状病毒 (COVID-19) 大流行的影响

5. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（依药物类别）

6. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（依分销管道）

7. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（按地区）

第八章竞争态势

第九章章节

Market Dynamics

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Polycystic Ovary Syndrome (PCOS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, 2020 - 2032, (US$ Million)

6. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Distribution Channel, 2020 - 2032, (US$ Million)

7. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region, 2020 - 2032, (US$ Million)

8. Competitive Landscape

9. Section

卵巢（PCOS）治疗市场（按药物类别、分销管道和地区）

Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, By Distribution Channel, By Region

市场动态

本研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 全球卵巢症候群 (PCOS) 治疗市场-冠状病毒 (COVID-19) 大流行的影响

5. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（依药物类别）

6. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（依分销管道）

7. 2020 年至 2032 年全球多卵巢症候群 (PCOS) 治疗市场（按地区）

第八章 竞争态势

第九章 章节

Market Dynamics

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Polycystic Ovary Syndrome (PCOS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, 2020 - 2032, (US$ Million)

6. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Distribution Channel, 2020 - 2032, (US$ Million)

7. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region, 2020 - 2032, (US$ Million)

8. Competitive Landscape

9. Section

第一章调查目的与前提条件

第二章市场展望

第八章竞争态势

第九章章节